Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

doi:10.1038/labinvest.2008.27

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

Laboratory investigation; a journal of technical methods and pathology - 1 Jul 2008

Majewski Tadeusz, Lee Sangkyou, Jeong Joon, Yoon Dong-Sup, Kram Andrzej, Kim Mi-Sook, Tuziak Tomasz, Bondaruk Jolanta, Lee Sooyong, Park Weon-Seo, Tang Kuang S, Chung Woonbok, Shen Lanlan, Ahmed Saira S, Johnston Dennis A, Grossman H Barton, Dinney Colin P, Zhou Jain-Hua, Harris R Alan, Snyder Carrie, Filipek Slawomir, Narod Steven A, Watson Patrice, Lynch Henry T, Gazdar Adi, Bar-Eli Menashe, Wu Xifeng F, McConkey David J, Baggerly Keith, Issa Jean-Pierre, Benedict William F, Scherer Steven E, Czerniak Bogdan

Abstract excerpt

The search for the genomic sequences involved in human cancers can be greatly facilitated by maps of genomic imbalances identifying the involved chromosomal regions, particularly those that participate in the development of occult preneoplastic conditions that progress to clinically aggressive invasive cancer. The integration of such regions with human genome sequence variation may provide valuable clues about...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosome Mapping

Share to Chromosomes, Human, Pair 13

Share to Microsatellite Repeats

Share to Retinoblastoma Protein

Share to Urinary Bladder

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Open in PubMed Open full text

Identifiers

PMID: 18458673
DOI: 10.1038/labinvest.2008.27
PMCID: PMC2849658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.PMID 18458673Read ↗

High-resolution whole-organ mapping with SNPs and its significance to early events of carcinogenesis.Semantic proximity Read ↗

Identification of bladder cancer biomarkers by genomic approachesSemantic proximity Read ↗

Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia.Semantic proximity Read ↗

Forerunner genes contiguous to RB1 contribute to the development of <i>in situ</i> neoplasiaSemantic proximity Read ↗

Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression.Semantic proximity Read ↗

The evolution of bladder cancer genomics: What have we learned and how can we use it?Semantic proximity Read ↗

Genetic and Epigenetic Alterations in Bladder CancerSemantic proximity Read ↗

The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studiesSemantic proximity Read ↗

The Origin of Bladder Cancer from Mucosal Field EffectsSemantic proximity Read ↗

Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.Semantic proximity Read ↗

Origins of Bladder CancerSemantic proximity Read ↗

The Cancer Genome Atlas Project in Bladder Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.